Gene: MIR100HG

399959
AGD1|linc-NeD125|lncRNA-N2
mir-100-let-7a-2-mir-125b-1 cluster host gene
ncRNA
11q24.1
Ensembl:ENSG00000255248 MIM:615965
NC_000011.10
SNP Mapped
1   ANCO-SNPs
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.051e-1 (AD)  1.333e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs492085chr11:122123992 (GRCh38.p7)G>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIR100HG mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIR100HG mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of MIR100HG mRNA29067470
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of MIR100HG gene27153756
C584509C646 compoundC646 compound results in decreased expression of MIR100HG mRNA26191083
D003907DexamethasoneDexamethasone results in decreased expression of MIR100HG mRNA25047013
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of MIR100HG mRNA27392435
D002945CisplatinCisplatin results in decreased expression of MIR100HG mRNA27392435
D002117CalcitriolCalcitriol results in decreased expression of MIR100HG mRNA26485663
D005557FormaldehydeFormaldehyde results in decreased expression of MIR100HG mRNA28937961
C492448ICG 001ICG 001 results in decreased expression of MIR100HG mRNA26191083
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of MIR100HG mRNA27392435
C544151jinfukangjinfukang results in decreased expression of MIR100HG mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of MIR100HG mRNA26752646
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of MIR100HG mRNA28001369
C523799MRK 003MRK 003 results in decreased expression of MIR100HG mRNA21169257
C570897NSC668394NSC668394 results in increased expression of MIR100HG mRNA27137931
C510784ormosil[ormosil binds to Polyethylene Glycols] which results in increased expression of MIR100HG mRNA24888373
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIR100HG mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of MIR100HG mRNA26272509
D011092Polyethylene Glycols[ormosil binds to Polyethylene Glycols] which results in increased expression of MIR100HG mRNA24888373
D014635Valproic AcidValproic Acid affects the expression of MIR100HG mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of MIR100HG mRNA23179753
D014635Valproic AcidValproic Acid results in increased expression of MIR100HG mRNA28001369

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

There is no Interaction data for this gene.

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal